RTI Surgical Inc. (NASDAQ:RTIX) was downgraded by TheStreet from a “hold” rating to a “sell” rating in a research note issued to investors on Thursday.

A number of other equities analysts have also recently issued reports on the stock. Zacks Investment Research cut shares of RTI Surgical from a “hold” rating to a “sell” rating in a research report on Friday, October 28th. Craig Hallum lowered shares of RTI Surgical from a “buy” rating to a “hold” rating and reduced their target price for the stock from $6.00 to $4.00 in a report on Thursday, July 28th.

Shares of RTI Surgical (NASDAQ:RTIX) opened at 2.80 on Thursday. The firm’s market capitalization is $162.84 million. The firm has a 50-day moving average of $2.95 and a 200 day moving average of $3.38. RTI Surgical has a 12-month low of $2.50 and a 12-month high of $4.65.

Large investors have recently bought and sold shares of the company. Cornerstone Capital Management Holdings LLC. raised its stake in RTI Surgical by 32.8% in the third quarter. Cornerstone Capital Management Holdings LLC. now owns 155,200 shares of the company’s stock worth $485,000 after buying an additional 38,300 shares during the last quarter. Panagora Asset Management Inc. raised its stake in RTI Surgical by 73.6% in the third quarter. Panagora Asset Management Inc. now owns 48,087 shares of the company’s stock worth $150,000 after buying an additional 20,382 shares in the last quarter. D. E. Shaw & Co. Inc. raised its stake in RTI Surgical by 0.6% in the third quarter. D. E. Shaw & Co. Inc. now owns 971,085 shares of the company’s stock worth $3,039,000 after buying an additional 5,675 shares in the last quarter. The Manufacturers Life Insurance Company purchased a new stake in RTI Surgical during the third quarter worth approximately $135,000. Finally, SECOR Capital Advisors LP raised its stake in RTI Surgical by 3.4% in the third quarter. SECOR Capital Advisors LP now owns 112,292 shares of the company’s stock worth $351,000 after buying an additional 3,702 shares in the last quarter. 79.04% of the stock is currently owned by hedge funds and other institutional investors.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

5 Day Chart for NASDAQ:RTIX

Receive News & Stock Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related stocks with our FREE daily email newsletter.